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The development of RNA interference (RNAi) techniques 
ranks as one of the major technical advances of recent 
years  in  experimental  biology.  These  techniques  have 
provided investigators with powerful tools for disrupting 
gene expression with unprecedented ease. At long last, 
functional genetic screens in cultured cells are possible. 
While these screens are now widely used, they often yield 
‘off-target  hits’,  where  reproducible  functional  readouts 
occur in the absence of disruption of the intended target 
gene. A recent report by Sudbery et al. [1] in BMC Genomics 
describes a systematic investigation of off-target hits in 
an RNAi screen for modulators of apoptosis induced by 
TNF-related apoptosis inducing ligand (TRAIL-induced 
apoptosis). The results unexpectedly show that off-target 
hits are enriched for common sequence motifs resem-
bling  the  targeting  sites  (‘seed  regions’)  of  microRNAs 
(miRNAs),  endogenous  noncoding  RNAs  that  repress 
expression of mRNAs. These findings suggest technical 
improvements  in  screening  methodologies  using  small 
interfering  RNAs  (siRNAs),  and  on  a  broader  level, 
demonstrate the powerful ability of miRNAs to modulate 
biological pathways.
microRNA-like off-target silencing by siRNAs
One of the more popular embodiments of RNAi tech-
nology involves the use of siRNAs, which are readily used 
for gene silencing in a variety of cultured cells [2]. The 
impact of their discovery is evidenced by the fact that an 
entire  industry  has  developed  to  supply  standardized 
siRNAs and the reagents for their use. While siRNAs are 
usually  designed  to  silence  perfectly  matched  specific 
mRNA targets, they can also silence multiple unintended 
targets.  Silencing  of  unintended  targets  occurs  when 
siRNAs  act  like  miRNAs,  which  repress  expression  of 
specific  mRNAs  by  binding  short  target  sequences  in 
their  3’  untranslated  regions  (UTRs)  that  match  the 
miRNA ‘seed regions’ (nucleotides 1 to 8). Because of the 
short  lengths  of  these  targeting  sites,  they  are  found 
frequently in transcripts and an individual miRNA can 
therefore  have  many  targets.  Unintended,  miRNA-like 
silencing by siRNAs also involves target sites that match 
siRNA seed regions, and also involves many transcripts. 
While  perfectly  matched  targets  often  are  silenced 
robustly  (up  to  around  tenfold),  miRNA-like  off-target 
regulations  are  weak  (generally  less  that  twofold). 
Because of their low magnitude, miRNA-like off-target 
regulations  are  most  easily  detected  using  statistical 
techniques that measure small changes in the expression 
of  many  genes.  miRNAs  modulate  expression  of  most 
mammalian genes and have been termed ‘micromanagers 
of gene expression’ [3].
miRNA-like  off-target  silencing  has  been  well  docu-
mented  [4],  but  its  consequences  in  siRNA  functional 
screens are not well understood. Even applying technical 
standards for calling hits in siRNA screens [5], it is still 
common to find off-target screen hits. It was noted that 
top  screen  hits  may  result  from  off-target  effects 
mediated  by  shared  sequence  identity  in  siRNA  seed 
regions [6]. However, a systematic global examination of 
the effects of miRNA-like off-target silencing in siRNA 
screens has not been reported.
Enrichment of seed-sequence motifs in siRNA 
screening hits
Sudbery et al. [1] performed an siRNA screen for modu-
lators  of  TRAIL-induced  apoptosis  in  HeLa  cells.  The 
screen utilized a sub-genomic siRNA library designed to 
target the ‘druggable genome’ (that is, that part of the 
genome encoding potential drug targets such as protein 
kinases,  G-protein  coupled  receptors,  and  so  on),  and 
one caveat to these studies is that the results might be 
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for the library. While the technical quality of the screen 
was good, and Sudbery et al. found that siRNAs to several 
well-documented  apoptosis  pathway  members  behaved 
as  expected  in  the  assay,  they  also  found  that  a  large 
fraction of the top-scoring siRNAs was confirmed as off-
target hits.
These findings are reminiscent of previous findings by 
Lin  et  al.  [6]  that  screening  enriches  for  siRNAs  with 
specific seed sequences. When Sudbery et al. examined 
their  top-scoring  siRNAs,  they  found  repeated  occur-
rences of several seed sequences, including seeds found 
in the human miRNAs miR-26a, miR-145 and miR-384. 
Of particular importance, the addition of a miR-26a seed 
hexamer motif, ACTTGA, to an inert sequence specifi-
cally conferred protection against TRAIL-induced apop-
tosis.  In  addition,  bona  fide  miR-26a,  miR-145  and 
miR-384 sequences blocked TRAIL-induced apoptosis in 
a  number  of  cell  types.  Taken  together,  these  findings 
suggest  that  these  screening  experiments  enriched  for 
siRNAs  with  miRNA-like  off-target  activity.  In  other 
words,  a  high-scoring  siRNA  hit  was  more  likely  to 
possess miRNA-like activity than activity against a single 
gene target.
miRNA-like versus single-target hits
The results of Sudbery et al. [1] suggest ways to improve 
siRNA screens. It is common practice to call hits from 
screens only after at least two different siRNAs that target 
the  same  gene  yield  the  same  result  [5].  However, 
Sudbery et al. show that different siRNAs can sometimes 
trigger the same miRNA-like off-target phenotype. While 
such  examples  would  be  expected  to  be  relatively 
uncommon, they do indeed occur. This suggests that a 
better criterion for hit calling is to verify the phenotype 
with two independent siRNAs not present in the original 
siRNA library.
Another area for potential improvement is in siRNA 
library  design.  The  propensity  for  miRNAs  to  trigger 
observable  phenotypes  suggests  that  sequences 
matching miRNA seed sequences should be filtered out 
during library design. Filtering must be balanced against 
the need to maintain sufficient sequence diversity space 
for selecting sequences with optimal on-target activity. 
These considerations suggest that more work will need 
to be done to optimize siRNA library design parameters. 
The  results  from  this  study  should  provide  a  strong 
incentive  for  investigators  to  purchase  libraries  from 
vendors  who  use  design  techniques  to  avoid  miRNA-
like off-target effects.
Technical concerns aside, one of the striking findings 
from the study of Sudbery et al. [1] was how strongly and 
frequently miRNA-like hits scored in their screen. Eight 
off-target hits (three of which match a seed hexamer of 
miR-26a)  gave  stronger  phenotypes  than  the  top  on-
target hit, MYC-associated factor X (MAX). Moreover, 
transfer of the miR-26a seed hexamer motif to a negative 
control siRNA conferred a phenotype as strong as that of 
the  positive  control  used  in  the  assays,  an  siRNA 
targeting caspase 8. Thus, seed pairing may be sufficient 
Figure 1. A model for the propensity for off-target hits in siRNA screens. Shown is a hypothetical, directed acyclic network or pathway with 
multiple branches contributing to a complex phenotype. This scheme resembles current views on extrinsic and intrinsic apoptotic pathways that 
drive cell-survival decisions [10]. (a) Some siRNAs may be effective at disrupting a pathway. An siRNA targeting a root node (blue line) will disrupt all 
downstream flow through the pathway. (b) Other siRNAs may be ineffective at disrupting a pathway. For example, an siRNA targeting a daughter 
node (magenta) will be ineffective at inhibiting downstream flow because it does not block all parallel paths to the phenotype. (c) microRNA-like 
hits (yellow) may be more effective pathway blockers. Because microRNAs have multiple targets, they can block multiple paths to a phenotype.
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most common type of conserved miRNA target site in 
mammals  [7].  The  top-scoring  hits  in  the  screen  des-
cribed by Lin et al. were also miRNA-like [6].
miRNA-like off-target hits can, therefore, often score 
more favorably in siRNA screens than siRNAs that target 
single genes. Why should this be? Perhaps siRNA design 
algorithms remain suboptimal, so that many siRNAs do 
not  optimally  silence  their  intended  targets.  Another 
possibility is that triggering a given phenotype is a func-
tion of the number of tests being made. Because miRNA-
like activity of siRNAs involves the regulation of so many 
genes, perhaps there is a better chance of scoring simply 
because there are more ‘shots on goal’.
Another possibility to explain selection for miRNA-like 
hits is that the miRNA mode of target regulation is more 
effective at modulating complex phenotypes (Figure 1). 
siRNAs targeting single genes may effectively block flow 
through a pathway at certain points, but not at others. 
Unaffected target nodes in a network could, for example, 
represent  points  where  there  are  parallel  paths  to  a 
pheno  type. On the other hand, miRNA-like hits may be 
more  effective  because  they  are  able  to  block  multiple 
paths  toward  the  measured  phenotype(s).  miRNA-like 
regu  lation is likely to recapitulate natural and evolution-
arily selected modes of pathway control.
Selection of miRNA hits may therefore reflect the role 
of miRNAs as natural micromanagers of biological path-
ways [3]. A corollary of this idea is that an siRNA that 
does not match a true miRNA would be likely to trigger a 
spectrum  of  off-target  regulations  that  have  not  been 
selected  during  evolution.  Importantly,  miRNA  seed 
matches  are  disproportionally  represented  relative  to 
non-miRNA seed matches in the hit lists from Sudbery et 
al. [1]. miRNA seed hexamers comprise around 25% (4 of 
16)  of  significantly  scoring  seed  hexamers,  but  only 
around 8% (348 of 4,096) of all possible hexamer words 
(hypergeometric  P-value  approximately  9e-3).  This  is 
consistent  with  the  notion  that  certain  miRNAs  have 
been  selected  during  evolution  to  regulate  TRAIL-
induced apoptosis.
The studies of Sudbery et al. [1] are important because 
they open up new ways of thinking about siRNA screen-
ing results. They suggest ways to improve hit calling and 
siRNA  library  design.  Moreover,  they  implicate  siRNA 
screens as an experimental tool for examining the role of 
miRNAs on pathway regulation. It will be important to 
extend these studies to other siRNA functional screens, 
including full genome-scale screens [8]. With full genome 
screens, it may be possible to identify key miRNA targets 
by  matching  single  gene  screen  hits  with  targets  of 
miRNA  sequences  overrepresented  in  off-target  hits. 
This approach has been used to identify multiple miRNA 
targets whose silencing by siRNAs triggers a cell-growth 
phenotype [9]. The study of Sudbery et al. suggests that 
further surprises lie ahead as to the extent that miRNA 
micromanagers affect biological pathways.
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